{
    "organizations": [],
    "uuid": "0d5fb763f63a3eda92cde9612b8616fdc97dd2f3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-australian-pharmaceutical-industri/brief-australian-pharmaceutical-industries-expects-fy-npat-to-be-marginally-above-that-of-fy17-idUSFWN1PE1CA",
    "ord_in_thread": 0,
    "title": "BRIEF-Australian Pharmaceutical Industries Expects FY NPAT To Be Marginally Above That Of FY17​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 22 (Reuters) - Australian Pharmaceutical Industries Ltd :\n* FY NPAT EXPECTED TO BE MARGINALLY ABOVE THAT OF FY17​ * EXPECTS HALF YEAR NET PROFIT AFTER TAX (NPAT) FOR PERIOD ENDING 28 FEB 2018 TO BE ABOUT $26.5 MILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-22T05:40:00.000+02:00",
    "crawled": "2018-01-22T20:41:07.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "australian",
        "pharmaceutical",
        "industry",
        "ltd",
        "fy",
        "npat",
        "expected",
        "marginally",
        "expects",
        "half",
        "year",
        "net",
        "profit",
        "tax",
        "npat",
        "period",
        "ending",
        "feb",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}